CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Ethics

ONCOLOGY. Vol. 23 No. 4
Pages: 1  2  3  4  5  
Previous Next
YOUR OLDER PATIENT 

Health Literacy, Communication, and Treatment Decision-Making in Older Cancer Patients

By Sunil Amalraj, MD1, Chelsea Starkweather, MPH2, Christopher Nguyen, BS3, Arash Naeim, MD, PhD4 | April 13, 2009
1Fellow, UCLA Geriatric Oncology Training Program 2Research Assistant 3Medical Student 4Assistant Professor of Medicine, University of California, Los Angeles David Geffen School of Medicine, Division of Hematology-Oncology, Los Angeles, California

Effective communication between health-care professionals and patients is essential for the delivery of high-quality health care. Communication issues are often a critical factor in litigation.[34] Research has suggested that effective communication during medical encounters positively influences patient recovery, pain control, adherence to treatment, satisfaction, and psychological functioning.[3,35] Due to the threat of mortality from the diagnosis of cancer, uncertainty of therapy efficacy, and the physical and emotional stress of undergoing chemotherapy, patients must obtain a high level of complex information during communications with their treating physician.[36,37]

Older adults diagnosed with cancer are the population group considered to be at highest risk for poor communication with health professionals. The older patient is less likely to be assertive and ask in-depth questions. Overall physician responsiveness (ie, the quality of questions, informing, and support) is better with younger patients than with older patients, and there is less concordance on the major goals and topics of the visit between physicians and older patients than between physicians and younger patients.[38,39]

Physician-Patient Communication and Oral Literacy Demand The underpinning of effective verbal communication in the medical encounter is the interaction between a patient’s health literacy level and the quality of dialogue between patient and physician. “Oral literacy demand” can be defined as the aspects of dialogue that challenge patients with low literacy skills.[40] During conversations, the general language complexity increases with the greater number of sentences in the passive voice and faster dialogue pacing, both of which have negative effects on comprehension.[40]

The use of technical terminology is an important component of oral literacy demand. Research done on adult literacy of genetic information presented during genetic counseling sessions suggests that literacy demand was proportional to the use of technical terms.[41] A doctor’s choice of vocabulary can affect patient satisfaction immediately after a general practice consultation, and if the doctor uses the same vocabulary as the patient, patient outcomes improve.[42] In addition, studies have found increased “dialogue density”—or the duration of uninterrupted speech by a physician—correlates with greater oral literacy demand.[43] A review 152 prenatal and cancer pretest genetic counseling sessions with simulated clients found that the higher use of technical terms, and the more dense and less interactive the dialogue, the less satisfied the simulated clients were and the lower their ratings were of counselors’ nonverbal effectiveness.

In addition, patients with low health literacy are less likely to ask their physician to slow down the dialogue and repeat information when their understanding is compromised.[44] Interventions to modify health-care provider use of technical terms, general language complexity, and structural characteristics of dialogue can enhance overall communication by decreasing patient oral literacy demand.[40]

Communication Barriers in the Elderly
The literature suggests that evaluating such factors as memory decline and sensory deficits are essential in geriatric patient medical visits. These common age-related communication barriers are often overlooked in the oncology consultation and frequently compromise the quality of communications. There is a broad range of cognitive loss among individuals with dementia, and unless the physician is trained to uncover this problem, it can be missed in patients with mild or even moderate loss.[45] For example, the 1999–2001 National Health Interview Surveys (NHIS) indicate that 2.3 million (7.1%) community dwelling people aged 65 and over are limited by memory impairment or confusion, while 800,000 (2.4%) are limited by senility and dementia.[46]

In addition to cognition, hearing and vision are important components of communication. Presbycusis, or decreased hearing of higher frequency sounds, is one of the most common and significant sensory changes that affect elderly people. The incidence of sensorineural hearing loss increases each decade so that by the 7th and 8th decades, 35% to 50% of older adults have hearing impairment.[47] Vision loss also has a significant impact on physician-patient interaction because visual cues are vital in interaction. After age 65 there is a decrease in visual acuity, contrast sensitivity, glare intolerance, and visual fields. Based on the 1997–2002 NHIS, 15% to 25% of older adults had visual impairment.[47] The combination of both hearing and visual impairment among elders aged 65 to 79 was 7% and increased to 17% for individuals aged 80 and over.[47]

Physician visits for elderly patients with these functional impairments may be so difficult to coordinate that they result in frequently missed appointments. When these frail older patients finally do see the physician, the visits may be emotionally and physically stressful for them, limiting effective communication.[10,39]

Decision-Making

Low levels of health literacy present challenges to any decision-making paradigm,[48,49] especially in the case of complex cancer treatment decisions in the elderly. Complexity in the cancer treatment decision process originates from the fact that selection of therapy is unique to every patient. Typically, several treatment options are possible and the oncologist and patient must together carefully weigh the risk of toxicity against potential benefit. Patient preferences, quality of life, and social responsibilities must be considered along with the stage of disease, biologic characteristics of the tumor, and comorbid illnesses.

Cancer Treatment Decisions and Self-Efficacy One important factor in decision-making is “self-efficacy,” or confidence in one’s ability to understand and communicate with physicians. Patients with high self-efficacy have been found to have fewer episodes of depression and develop more realistic goals. An important aspect of self-efficacy is the sense of control and involvement in the treatment, which has been associated with several desirable outcomes including greater patient satisfaction, increased adherence to treatment, and positive treatment outcomes in elderly patients. Evidence suggests that cancer patients who report greater self-efficacy are better adjusted and experience greater quality of life than those with low self-efficacy.[50]

Pages: 1  2  3  4  5  
Previous Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Don't Tell Me Anything Negative
ONCOLOGY,  May 15, 2013
A Common Theme Among Ethical Issues in Oncology: The Need to Individualize Advanced Cancer Care
ONCOLOGY,  February 15, 2013
Rationing Healthcare: Who's Responsible?
ONCOLOGY,  February 15, 2013
Ethical Challenges in Oncology, Explored Through a Series of Vignettes
ONCOLOGY,  February 15, 2013
Ethics of Cost Containment for Cancer Therapies
August 23, 2012
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Ethics In Oncology
Evidence on Ethics In Oncology
Guidelines on Ethics In Oncology
Patient Education on Ethics In Oncology
Clinical Trials on Ethics In Oncology
Practical Articles on Ethics In Oncology
Research and Reviews on Ethics In Oncology
All "Ethics In Oncology" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy